Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Seifegebriel Teshome"'
Autor:
Shimelis Teshome Ayalneh, Biruk Yeshitela Beshah, Yeonji Jeon, Seifegebriel Teshome, Tomas Getahun, Solomon Gebreselassie, Se Eun Park, Mekonnen Teferi, Woldaregay Erku Abegaz
Publikováno v:
PLoS ONE, Vol 19, Iss 8, p e0306691 (2024)
BackgroundThe worldwide increase in multidrug resistance is a major threat to public health. One particular concern is the presence of Escherichia coli strains that carry Extended-Spectrum β-Lactamase (ESBL) and Carbapenemase enzymes, which can make
Externí odkaz:
https://doaj.org/article/e7f96736cbdb478e80df8e7716d80c86
Autor:
Kidist Zealiyas, Seifegebriel Teshome, Aklilu Feleke Haile, Christoph Weigel, Ayinalem Alemu, Wondwossen Amogne, Getnet Yimer, Tamrat Abebe, Nega Berhe, Elshafa Hassan Ahmed, Robert A. Baiocchi
Publikováno v:
Frontiers in Microbiology, Vol 14 (2023)
BackgroundEpstein–Barr virus (EBV) is a human lymphotropic herpesvirus with a causative agent in cancer. There are two genotypes of EBV (EBV genotype 1 and EBV genotype 2) that have been shown to infect humans. This study aimed to characterize the
Externí odkaz:
https://doaj.org/article/a497d68757b24dd5a3dbfbfbac59dda3
Autor:
Seifegebriel Teshome, Kidist Zealiyas, Abdulaziz Abubeker, Fisihatsion Tadesse, Jayalakshmi Balakrishna, Christoph Weigel, Tamrat Abebe, Elshafa Hassan Ahmed, Robert A. Baiocchi
Publikováno v:
Microorganisms, Vol 11, Iss 10, p 2606 (2023)
The Epstein-Barr virus (EBV) is a known oncogenic virus associated with various lymphoma subtypes throughout the world. However, there is a lack of information regarding EBV prevalence in lymphoma patients, specifically in Ethiopia. This study aimed
Externí odkaz:
https://doaj.org/article/68ae079755974ea39aa54420f7bef0ab
Autor:
Seifegebriel Teshome, Elshafa Hassan Ahmed, Kidist Zealiyas, Abdulaziz Abubeker, Fisihatsion Tadesse, Christoph Weigel, Robert A. Baiocchi, Tamrat Abebe
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 18, p 13891 (2023)
Epstein–Barr virus (EBV) is an oncogenic herpes virus associated with several human malignancies. Two main EBV genotypes (type 1 and type 2) distinguished by the differences in EBV nuclear antigens are known. Geographic variability in these genetic
Externí odkaz:
https://doaj.org/article/554693ccd3a4446fbf156d4af8375c0d
Autor:
Daniel Getacher Feleke, Habtye Bisetegn, Getamesay Zewudu, Yohannes Alemu, Seifegebriel Teshome Feleke
Publikováno v:
Journal of Tropical Medicine, Vol 2023 (2023)
Background. Food handlers should be screened periodically for intestinal parasitic infections, and they should be treated to reduce intestinal parasite transmission to consumers through contaminated foods and drinks. Therefore, this study aimed to as
Externí odkaz:
https://doaj.org/article/615d6db8b68143daa5d18bf20af57d57
Autor:
Kidist Zealiyas, Seifegebriel Teshome, Nega Berhe, Wondwossen Amogne, Aklilu Feleke Haile, Ebba Abate, Getnet Yimer, Christoph Weigel, Elshafa Hassan Ahmed, Tamrat Abebe, Robert Baiocchi
Publikováno v:
Viruses, Vol 15, Iss 8, p 1743 (2023)
Epstein–Barr virus (EBV) is a well-known risk factor for the development of nasopharyngeal carcinoma, Hodgkin’s lymphoma (HL), and Non-Hodgkin’s lymphoma (NHL). People with HIV infection (PWH) are at increased risk for EBV-associated malignanci
Externí odkaz:
https://doaj.org/article/b8dcb7c43651479aa0a57a5639c2ac6e
Autor:
Melkamu Bedimo Beyene, Seifegebriel Teshome, Yehenew A., Zewdu Terefework, Antoine R. Stuitje, Tamrat Abebe, Habtamu B. Beyene
Publikováno v:
PLoS ONE, Vol 17, Iss 8 (2022)
Background Malaria elimination effort is hampered not only by the lack of effective medication but also due to the lack of sensitive diagnostic tools to detect infections with low levels of parasitemia. Therefore, more sensitive and specific high-thr
Externí odkaz:
https://doaj.org/article/9f4b2a5602b94bed8590323b01564d0b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Seifegebriel Teshome, Habtamu Biazin
Approximately 2 billion people worldwide are infected with HBV and more than 240 million are chronic carriers. The World Health Organization officially launched the introduction of the hepatitis B vaccine for children in 1980. Since then, different c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d0a6981adfb60175d3719e5e69da26d
https://doi.org/10.5772/intechopen.99970
https://doi.org/10.5772/intechopen.99970
Autor:
Zelalem Desalegn, Shemse Sebre, Meron Yohannes, Aminu Seman, Welelta Shiferaw, Muluneh Ademe, Habtamu Biazin, Ededia Firdawoke, Yehenew Asemamaw, Brhanu Teka, Seifegebriel Teshome, Wondwossen Amogne, Adamu Addissie, Yirgu Gebrehiwot, Eva Kantelhardt, Tamrat Abebe
Publikováno v:
Infection and drug resistance. 15
Zelalem Desalegn,1,* Shemse Sebre,1,* Meron Yohannes,2 Aminu Seman,1 Welelta Shiferaw,3 Muluneh Ademe,1 Habtamu Biazin,1 Ededia Firdawoke,1 Yehenew Asemamaw,1 Brhanu Teka,1 Seifegebriel Teshome,1 Wondwossen Amogne,4 Adamu Addissie,5,6 Yirgu G
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a16dd38e4497af41944756a8c79125a3
https://pubmed.ncbi.nlm.nih.gov/35965848
https://pubmed.ncbi.nlm.nih.gov/35965848